Anyone have a hunch who was that 25,000 share trade in the last hour? And why it didn't dump the price worse that it did concidering the low volumn. Must be buys for anything below 8.
Hey Dude! I see that you are a complainer on this
board too. Exactly how many good things do you have to
say about Newt? The only thing I can thing of is that
he is gone from Congress. To answer your
question...the stock will 'follow those numbers' when people are
willing to pay more for the stock.
Have a nice day.
<<1.1 mil for 2 days of sales. That
translates to $45 mil. per quarter, $180 mil per
As Icordone mentioned in an earlier note, the first
2 days of sales are encouraging because it is an
indication that there will probably be significant off-label
usage. However, it's going to take time to build up
sales volume from here. The results for the first 2
days is what was bought to stock the shelves and now
someone has to buy it. I haven't seen any recent analyst
estimates but would be really ancouraged if we saw $5-6
million in sales over the next quarter. Given the recent
multiple myeloma news, you have to think that oncologists
will be encouraged to try Thalomid and there are a
number of other serious diseases where the company has
built up a body of evidence that the drug actually
works. I think that a number of people are missing the
fact that Wall Street attached HUGE valuations to
anti-TNF products being developed by companies such as
Chiron and Immunex in the early 1990's, and these were
injectable products (MAb's) that failed in the
Celgene has an orally-administered drug. I don't think
that Thalomid is going to be a billion-dollar drug,
but some of the second-generation analogs might be.
<<With CELG reporting Thalomid sales of
$1MM in Q3 (2 days) for a drug which is officially
approved for an illness which aflicts only about 500
people in the US, and with 2000+ doctors signed up,
sounds like we may want to prepare ourselves for
significant off-label prescription. CELG may have the
potential to outperform both SEPR and ENMD in the coming
Yes! I couldn't agree with you more. It may be a
little rough over the near term, but people aren't going
to shy away from using the drug because it actually
works. An oral inhibitor of TNF is a *nice* thing. My
only concern is dilution of equity, am hoping that
they will be able to raise the cash that they need on
moderately favorable terms.
This stock is like Newt Gingrich. No matter how
many good things it has to say, it still takes a
1.1 mil for 2 days of sales. That
translates to $45 mil. per quarter, $180 mil per year.
When will the stock follow those
fridays press release is great- as good as we
could have expected . why do i feel like celgene will
loose value on monday? must bee the track record after
previous good news. tahank-you celgene for at least
releasing the two days sales data. now how about monthly
reports,please. nothing would be easier than releasing the
monthly data into your corporate website.
Do not know who was buying the
However, two events next week may help
First, I called the company today....Asked
Celgene Web Page which shows earnings
to be released
on NOV.9, 1998....I was informed
will be released the week of Nov.
day not given.
Next, the CEO will attend and
address a meeting
in NYC on Nov 11, 1998.(First Annual
Long CELG investor....
Still hanging long on this stock, have loaded up
on the dips but am running out of patience. CELG
needs some good news. Look what happened to GERN the
past 2 days and they have nothing, no product, no
earnings, and years before they will have them. All they
have are some cells in dishes and a lot of hope. Would
be great if CELG could move up on so little news.